| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -18.73% | -0.29% | -18.44% | -18.44% | — |
| 14d | 1 | +100.00% | -26.09% | -4.67% | -21.42% | -21.42% | — |
| 30d | 1 | +100.00% | -17.50% | +2.49% | -19.99% | -19.99% | — |
| 60d | 1 | +100.00% | -31.10% | +4.77% | -35.87% | -35.87% | — |
| 90d | 1 | +100.00% | -27.09% | +9.38% | -36.47% | -36.47% | — |
| 180d | 1 | +0.00% | +6.02% | +13.27% | -7.25% | -7.25% | — |
| 1y | 1 | +100.00% | -44.37% | +34.10% | -78.47% | -78.47% | — |
| 2y | 1 | +100.00% | -86.84% | +23.18% | -110.02% | -110.02% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Scientific Officer | 5,834 | $8.05 | $47.0K | 42,076 | Sep 9, 2020 | Sep 10, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 8,750 | — | — | 47,910 | Aug 17, 2020 | Aug 18, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 8,750 | — | — | 39,160 | Aug 14, 2020 | Aug 18, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jun 10, 2020 | Jun 11, 2020 ↗ | View → |